Status:
COMPLETED
Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography
Lead Sponsor:
Yonsei University
Conditions:
Abdominal Aortic Aneurysm (AAA)
Eligibility:
All Genders
19+ years
Brief Summary
Study purpose: This study will investigate anatomical factors associated with increased risk of major adverse aorta-related event and accelerated growth of abdominal aneurysm based on 3-dimensional an...
Detailed Description
Prospective single-arm multicenter registry
Eligibility Criteria
Inclusion
- \- abdominal aortic aneurysm with maximum diameter of 30-50 mm
Exclusion
- Age \<19 years
- Serum Cr\> 1.5mg/dL or eGFR\<30 mL/min
- Known allergic reactions to iodine contrast media
- Women in pregnancy or women of childbearing age
- Abdominal aortic aneurysms indicated for endovascular or surgical repair (symptomatic aneurysm or aneurysms with diameter \>5cm)
- Saccular type aneurysm, infected or inflammatory aneurysm
- Combined aortic dissection
- Aneurysms associated with genetic or connective tissue diseases (Marfan syndrome, Shprintzen-Goldberg syndrome, Loeys-Dietz syndrome, Takayasu's arteritis, Behcet's disease)
- Past history of surgical or endovascular repair of aorta
- Any surgical or endovascular repair planned within 1 year
- Life expectancy \< 1 year
Key Trial Info
Start Date :
April 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 17 2023
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT04333641
Start Date
April 3 2020
End Date
April 17 2023
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Severance Cardiovascular Hospital
Seoul, South Korea